Bank Of Montreal Imv Inc. Transaction History

Bank Of Montreal

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$0.47 - $0.75 $671 - $1,071	1,428 Added 1.51%	96,302 $62,000
Q2 2022 Aug 11, 2022	SELL	$0.56 - $1.45 $16,549 - $42,850	-29,552 Reduced 23.75%	94,874 $70,000
Q1 2022 May 12, 2022	BUY	$1.07 - $1.5 $33,458 - $46,905	31,270 Added 33.57%	124,426 $185,000
Q4 2021 Feb 11, 2022	SELL	$1.22 - $1.78 $57,402 - $83,750	-47,051 Reduced 33.56%	93,156 $130,000
Q3 2021 Nov 12, 2021	SELL	$1.35 - $2.16 $10,530 - $16,848	-7,800 Reduced 5.27%	140,207 $241,000
Q2 2021 Aug 12, 2021	BUY	$2.12 - $3.24 $313,774 - $479,542	148,007 New	148,007 $314,000

Ticker IMV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,452,200
Description
IMV Inc. operates as a clinical-stage immuno-oncology company. The company develops a portfolio of therapies based on DPX its immune-educating technology platform for treatment of solid and hematological cancers. The company's lead drug candidate includes maveropepimut-S, a DPX-based immunotherapy that targets survivin-expressing cells that is P...

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

Stay updated on Bank Of Montreal with notifications on news.